Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Rituksimab"'
Autor:
Bojana Šimunov, Iva Canjuga Sever, Bojana Maksimović, Željka Jureković, Lada Zibar, Branislav Čingel, Ivan Marageta, Snježana Šulc, Ksenija Vučur Šimić, Mladen Knotek, Mario Laganović
Publikováno v:
Liječnički vjesnik, Vol 146, Iss 5-6, Pp 170-174 (2024)
Cilj: Kalcijneurinski inhibitori (CNI) temelj su liječenja membranske nefropatije (MN). Nefrotoksičnost CNI-ja neželjeni je učinak koji ograničava njihovu primjenu. Željeli smo istražiti dugoročne ishode i bubrežnu funkciju u bolesnika lije
Externí odkaz:
https://doaj.org/article/a72cf39a2ea34d56b1096c73f3260261
Publikováno v:
Haseki Tıp Bülteni, Vol 61, Iss 3, Pp 210-213 (2023)
Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell
Externí odkaz:
https://doaj.org/article/282281d3328848f9ac548eb14f161a47
Publikováno v:
Liječnički vjesnik
Volume 145
Issue 1-2
Volume 145
Issue 1-2
SAŽETAK Autoimunosna hemolitička anemija je rijetka bolest imunosnog sustava koju karakterizira hemoliza vlastitih eritrocita uzrokovana autoprotutijelima i/ili aktiviranim komponentama komplementa. Ovisno o osnovnoj bolesti, autoimunosna hemoliti
Publikováno v:
Reumatizam
Volume 68
Issue 2
Volume 68
Issue 2
Sjögren’s syndrome (SS) is a chronic autoimmune disease in which chronic lymphocytic infiltration leads to progressive destruction of the exocrine glands and consequently causes the dry syndrome. The most commonly affected are the lacrimal and sal
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Volume: 44, Issue: 5 601-604
Osmangazi Tıp Dergisi
Osmangazi Journal of Medicine
Osmangazi Tıp Dergisi
Osmangazi Journal of Medicine
Non-Hodgkin Lymphoma (NHL) is the most common hematological malignancy. Diffuse Large B-Cell Lymphoma (DLBCL) is the most common histological type and the prognosis is variable. Rituximab+CHOP constitutes the standard treatment. Intravenous rituximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::4037ea0cebdb891c5dc8b6b871e72210
https://dergipark.org.tr/tr/pub/otd/issue/72671/1074211
https://dergipark.org.tr/tr/pub/otd/issue/72671/1074211
Autor:
Vujević, Anamarija
Cilj istraživanja: Prikupiti podatke o broju hospitaliziranih od COVID-19-a i limfoma u Kliničkom bolničkom centru (KBC) Split u razdoblju od ožujka 2020. godine do lipnja 2022. godine, razvrstati bolesnike po spolu, dobnim skupinama i hematološ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4112::d9e72bd5ecd1068114539d86981d1174
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1669/datastream/PDF
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1669/datastream/PDF
Цель: оценка эффективности анти-В-клеточной терапии у больных ревматоидным артритом с бронхиолитом. Материал и методы. У 156 больных ревм
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b3506f6e8436bdb4980f06ffebd6cbb
Autor:
Uršić, Dora, Kovačević, Ivana, Kardum, Željka, Masle, Ana Marija, Kovačević Stranski, Kristina, Šimac, Ana, Lucić, Mirna, Marošević, Antea, Milas-Ahić, Jasminka
Publikováno v:
Reumatizam
Volume 69
Issue Supp 1
Volume 69
Issue Supp 1